Cepheid Gets CE-IVD Mark for MRSA/SA Nasal Assay | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid has received the CE-IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its Xpert MRSA/SA Nasal molecular diagnostic test.

The test, which simultaneously detects methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus in less than one hour from a sample taken from the nasal carriage, is run on the firm's GeneXpert System. According to Cepheid, it is the 10th CE-IVD test for use on the system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.